Comment on Amicus Therapeutics to Acquire Rare Disease Company Scioderm, Inc. - CNNMoney

Amicus Therapeutics to Acquire Rare Disease Company Scioderm, Inc. - CNNMoney

XconomyAmicus Therapeutics to Acquire Rare Disease Company Scioderm, Inc.CNNMoneyCRANBURY, N.J., Aug. 31, 2015 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biotechnology company at the forefront of therapies for rare and orphan diseases, and Scioderm, Inc. a privately-held biopharmaceutical company focused on ...Amicus Acquires Scioderm, Adds Drug for Rare Skin Disorder to PipelineTheStreet.comWith $229M Deal, Amicus Gets a New Drug And Perhaps a VoucherXconomyAmicus bags PhIII rare disease drug in $847M Scioderm buyoutFierceBiotechall 4 news articles »

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News